5-羟色胺能
单胺类
神经科学
疾病
帕金森病
正电子发射断层摄影术
心理学
医学
血清素
病理
内科学
受体
作者
Edoardo Rosario de Natale,Heather Wilson,Marios Politis
出处
期刊:Progress in Brain Research
日期:2021-01-01
卷期号:: 303-338
被引量:7
标识
DOI:10.1016/bs.pbr.2020.11.001
摘要
Parkinson's disease (PD) is a neurodegenerative disorder characterized by the progressive degeneration of monoaminergic central pathways such as the serotonergic. The degeneration of serotonergic signaling in striatal and extrastriatal brain regions is an early feature of PD and is associated with several motor and non-motor complications of the disease. Molecular imaging techniques with Positron Emission Tomography (PET) have greatly contributed to the investigation of biological changes in vivo and to the understanding of the extent of serotonergic pathology in patients or individuals at risk for PD. Such discoveries provide with opportunities for the identification of new targets that can be used for the development of novel disease-modifying drugs or symptomatic treatments. Future studies of imaging serotonergic molecular targets will better clarify the importance of serotonergic pathology in PD, including progression of pathology, target-identification for pharmacotherapy, and relevance to endogenous synaptic serotonin levels. In this article, we review the current status and understanding of serotonergic imaging in PD.
科研通智能强力驱动
Strongly Powered by AbleSci AI